GlassScriptPhysician profile
Deborah S Watanabe
NPI 1760576979
$1,791.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $892 · 2020: $21.87 · 2021: $18.77 · 2022: $384 · 2023: $258 · 2024: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $355.80 | 2019-2024 | Idose |
| The Walman Optical Company | $300.00 | 2019 | |
| Alcon Vision LLC | $288.07 | 2019-2022 | |
| Biotissue Holdings INC. | $216.98 | 2022-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $177.47 | 2019 | |
| Allergan, INC. | $139.52 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $134.90 | 2024 | |
| Rxsight INC | $123.37 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece |
| Sun Pharmaceutical Industries INC. | $21.87 | 2020 | |
| Optos, INC. | $18.77 | 2021 | |
| Kala Pharmaceuticals, INC. | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Watanabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.